{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:12:32Z","timestamp":1780553552991,"version":"3.54.1"},"reference-count":42,"publisher":"AACN Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,15]]},"abstract":"<jats:p>Evidence-based approaches for the treatment of opioid use disorder include the use of opioid medications (methadone, buprenorphine, or naltrexone), collectively referred to as medication-assisted therapy. Patients receiving medication-assisted therapy may present in the acute care setting with pain, often related to planned surgical procedures to treat health issues that were not addressed before entering treatment. Because these medications act on the same receptors as do analgesic opioids\u2014and, in the cases of methadone and buprenorphine, have analgesic properties \u2014 managing acute pain in these patients can be challenging. Principles of effective pain management for these patients include continuing the usual medication-assisted therapy dose; using nonpharmacological and nonopioid pain management strategies as possible and immediate-release opioids, titrating to effect and monitoring for toxicity; anticipating tolerance and hyperalgesia; and establishing a collaborative treatment relationship with the medication-assisted therapy provider. Providing effective pain treatment supports ongoing recovery in patients with opioid use disorder.<\/jats:p>","DOI":"10.4037\/aacnacc2019328","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T19:05:21Z","timestamp":1576523121000},"page":"335-342","source":"Crossref","is-referenced-by-count":9,"title":["Acute Pain Management for Patients Receiving Medication-Assisted Therapy"],"prefix":"10.4037","volume":"30","author":[{"given":"Peggy","family":"Compton","sequence":"first","affiliation":[{"name":"Peggy Compton is Associate Professor, School of Nursing, University of Pennsylvania, 418 Curie Blvd, Room 402, Philadelphia, PA 19104 (pcompton@nursing.upenn.edu)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2471","reference":[{"key":"2022042504142886700_b1-0300335","unstructured":"Centers for Disease Control and Prevention\n          . CDC WONDER (Wide-ranging Online Data for Epidemiologic Research) website. http:\/\/wonder.cdc.gov. Published 2017. Accessed July 11, 2019."},{"issue":"17","key":"2022042504142886700_b2-0300335","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.2018.2844","article-title":"Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010\u20132016","volume":"319","author":"Jones","year":"2018","journal-title":"JAMA"},{"key":"2022042504142886700_b3-0300335","unstructured":"Centers for Disease Control and Prevention\n          . Today\u2019s heroin epidemic: more people at risk, multiple drugs abused. CDC Vital Signs website. http:\/\/www.cdc.gov\/vitalsigns\/heroin\/index.html. Published 2015. Accessed July 11, 2019."},{"key":"2022042504142886700_b4-0300335","unstructured":"Centers for Disease Control and Prevention\n          . Data overview. CDC Opioid Overdose website. https:\/\/www.cdc.gov\/drugoverdose\/data\/index.html. Published 2018. Accessed July 11, 2019."},{"key":"2022042504142886700_b5-0300335","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th"},{"issue":"6","key":"2022042504142886700_b6-0300335","first-page":"176","article-title":"Lapse and relapse following inpatient treatment of opiate dependence","volume":"103","author":"Smyth","year":"2010","journal-title":"Ir Med J"},{"issue":"4","key":"2022042504142886700_b7-0300335","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/ajad.12893","article-title":"A retrospective 4-year outcome study of veterans admitted to an acute inpatient detoxification unit for opioid use disorder","volume":"28","author":"Li","year":"2019","journal-title":"Am J Addict"},{"issue":"3","key":"2022042504142886700_b8-0300335","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/ajad.12711","article-title":"Antagonists in the medical management of opioid use disorders: historical and existing treatment strategies","volume":"27","author":"Bisaga","year":"2018","journal-title":"Am J Addict"},{"issue":"5","key":"2022042504142886700_b9-0300335","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J Addict Med"},{"key":"2022042504142886700_b10-0300335","doi-asserted-by":"crossref","DOI":"10.17226\/25310","volume-title":"Medications for Opioid Use Disorder Save Lives","author":"Leshner","year":"2019"},{"key":"2022042504142886700_b11-0300335","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.2147\/DDDT.S72543","article-title":"Advances in the delivery of buprenorphine for opioid dependence","volume":"11","author":"Rosenthal","year":"2017","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"2022042504142886700_b12-0300335","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/JAN.0000000000000160","article-title":"Nurse practitioner prescriptive authority for buprenorphine: from DATA 2000 to CARA 2016","volume":"28","author":"Fornili","year":"2017","journal-title":"J Addict Nurs"},{"issue":"1","key":"2022042504142886700_b13-0300335","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/10884602.2011.649026","article-title":"The prescribing of buprenorphine by advanced practice addictions nurses","volume":"23","author":"Strobbe","year":"2012","journal-title":"J Addict Nurs"},{"issue":"2","key":"2022042504142886700_b14-0300335","first-page":"CD001333","article-title":"Naltrexone maintenance treatment for opioid dependence","author":"Kirchmayer","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2022042504142886700_b15-0300335","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1360-0443.2006.01369.x","article-title":"Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review","volume":"101","author":"Johansson","year":"2006","journal-title":"Addiction"},{"issue":"7","key":"2022042504142886700_b16-0300335","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/add.14180","article-title":"Extended- release injectable naltrexone for opioid use disorder: a systematic review","volume":"113","author":"Jarvis","year":"2018","journal-title":"Addiction"},{"issue":"1","key":"2022042504142886700_b17-0300335","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1521-0391.2013.00308.x","article-title":"Chronic and acute pain and pain management for patients in methadone maintenance treatment","volume":"22","author":"Eyler","year":"2013","journal-title":"Am J Addict"},{"issue":"10","key":"2022042504142886700_b18-0300335","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1097\/j.pain.0000000000000246","article-title":"Further defining and conceptualizing opioid misuse in chronic pain","volume":"156","author":"Voon","year":"2015","journal-title":"Pain"},{"issue":"4","key":"2022042504142886700_b19-0300335","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0885-3924(00)00191-3","article-title":"Pain responses in methadone-maintained opioid abusers","volume":"20","author":"Compton","year":"2000","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"2022042504142886700_b20-0300335","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0376-8716(00)00200-3","article-title":"Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent","volume":"63","author":"Compton","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"2022042504142886700_b21-0300335","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/bjaed\/mkw049","article-title":"Perioperative management of opioid-tolerant patients","volume":"17","author":"Simpson","year":"2017","journal-title":"BJA Education"},{"issue":"6","key":"2022042504142886700_b22-0300335","first-page":"E739","article-title":"Long-term consequences of acute pain for patients under methadone or buprenorphine maintenance treatment","volume":"16","author":"Bounes","year":"2013","journal-title":"Pain Physician"},{"issue":"3","key":"2022042504142886700_b23-0300335","first-page":"VC07","article-title":"Spiritual well-being and associated factors with relapse in opioid addicts","volume":"11","author":"Noormohammadi","year":"2017","journal-title":"Clin Diagn Res"},{"issue":"9","key":"2022042504142886700_b24-0300335","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ejpain.2011.03.006","article-title":"Potential risk factors associated with risk for drop-out and relapse during and following withdrawal of opioid prescription medication","volume":"15","author":"Heiwe","year":"2011","journal-title":"Eur J Pain"},{"issue":"1","key":"2022042504142886700_b25-0300335","first-page":"E181","article-title":"Usefulness of the brief pain inventory in patients with opioid addiction receiving methadone maintenance treatment","volume":"19","author":"Dennis","year":"2016","journal-title":"Pain Physician"},{"issue":"5","key":"2022042504142886700_b26-0300335","first-page":"456","article-title":"Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists","volume":"43","author":"Schwenk","year":"2018","journal-title":"Reg Anesth Pain Med"},{"issue":"1","key":"2022042504142886700_b27-0300335","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AIA.0b013e31820aecd4","article-title":"Perioperative implications of buprenorphine maintenance treatment for opioid addiction","volume":"49","author":"Gevirtz","year":"2011","journal-title":"Int Anesthesiol Clin"},{"issue":"17-18","key":"2022042504142886700_b28-0300335","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1503\/cmaj.160290","article-title":"Caring for patients with opioid use disorder in the hospital","volume":"188","author":"Donroe","year":"2016","journal-title":"CMAJ"},{"issue":"3","key":"2022042504142886700_b29-0300335","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/ACO.0000000000000052","article-title":"The perioperative management of patients maintained on medications used to manage opioid addiction","volume":"27","author":"Bryson","year":"2014","journal-title":"Curr Opin Anesthesiol"},{"issue":"3","key":"2022042504142886700_b30-0300335","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.anclin.2018.04.002","article-title":"Perioperative considerations for the patient with opioid use disorder on buprenorphine, methadone, or naltrexone therapy","volume":"36","author":"Harrison","year":"2018","journal-title":"Anesthesiology Clin"},{"issue":"5","key":"2022042504142886700_b31-0300335","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0310057X1103900505","article-title":"Acute pain management in opioid-tolerant patients: a growing challenge","volume":"39","author":"Huxtable","year":"2011","journal-title":"Anaesth Intensive Care"},{"key":"2022042504142886700_b32-0300335","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2147\/TCRM.S141332","article-title":"The challenge of perioperative pain management in opioid-tolerant patients","volume":"13","author":"Coluzzi","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"2022042504142886700_b33-0300335","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bmjspcare-2016-001126","article-title":"Pain management strategies for patients on methadone maintenance therapy: a systematic review of the literature","volume":"7","author":"Taveros","year":"2017","journal-title":"BMJ Support Palliat Care"},{"issue":"4","key":"2022042504142886700_b34-0300335","first-page":"25","article-title":"Perioperative pain management in the chronic opioid user","volume":"4","author":"Sasek","year":"2016","journal-title":"J Orthop Physician Assist"},{"issue":"2","key":"2022042504142886700_b35-0300335","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/EJA.0b013e32835b822b","article-title":"Perioperative pain therapy in opioid abuse","volume":"30","author":"Stromer","year":"2013","journal-title":"Eur J Anaesthesiol"},{"issue":"2","key":"2022042504142886700_b36-0300335","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12630-018-1255-3","article-title":"The perioperative patient on buprenorphine: a systematic review of perioperative management strategies and patient outcomes","volume":"66","author":"Goel","year":"2019","journal-title":"Can J Anaesth"},{"issue":"1","key":"2022042504142886700_b37-0300335","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bpa.2014.03.001","article-title":"Multimodal therapy in perioperative analgesia","volume":"28","author":"Gritsenko","year":"2014","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"2","key":"2022042504142886700_b38-0300335","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/15360288.2013.788605","article-title":"Managing surgical pain in long-term opioid patients","volume":"27","author":"Brill","year":"2013","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"2","key":"2022042504142886700_b39-0300335","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3959(94)00168-E","article-title":"Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review","volume":"61","author":"Rapp","year":"1995","journal-title":"Pain"},{"issue":"10","key":"2022042504142886700_b40-0300335","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/pm\/pnx277","article-title":"Addressing the potential for perioperative relapse in those recovering from opioid use disorder","volume":"19","author":"Myers","year":"2018","journal-title":"Pain Med"},{"key":"2022042504142886700_b41-0300335","unstructured":"LeMoult\n              C\n            \n          . How do former opioid addicts safely get pain relief after surgery?https:\/\/www.npr.org\/sections\/health-shots\/2017\/04\/20\/519481712\/how-do-former-opioid-addicts-safely-get-pain-relief-after-surgery?Accessed April 20, 2017."},{"key":"2022042504142886700_b42-0300335","unstructured":"Mnookin\n              S\n            \n          . I told my doctors my drug history. Yet they gave me opioids without counseling. https:\/\/www.statnews.com\/2016\/06\/09\/opioid-prescriptions-addiction. Accessed March 1, 2017."}],"container-title":["AACN Advanced Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article-pdf\/30\/4\/335\/124122\/335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article-pdf\/30\/4\/335\/124122\/335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T04:14:59Z","timestamp":1650860099000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article\/30\/4\/335\/30601\/Acute-Pain-Management-for-Patients-Receiving"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,15]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12,15]]}},"URL":"https:\/\/doi.org\/10.4037\/aacnacc2019328","relation":{},"ISSN":["1559-7768","1559-7776"],"issn-type":[{"value":"1559-7768","type":"print"},{"value":"1559-7776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,15]]}}}